227 related articles for article (PubMed ID: 31823434)
1. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
4. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
[TBL] [Abstract][Full Text] [Related]
5. The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions.
Brédart A; Anota A; Dick J; Cano A; De Pauw A; Kop JL; Aaronson NK; Bleiker EM; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13173. PubMed ID: 31571365
[TBL] [Abstract][Full Text] [Related]
6. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
[TBL] [Abstract][Full Text] [Related]
7. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
Eijzenga W; Bleiker EM; Hahn DE; Kluijt I; Sidharta GN; Gundy C; Aaronson NK
Psychooncology; 2014 Aug; 23(8):862-9. PubMed ID: 24443031
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and detection of psychosocial problems in cancer genetic counseling.
Eijzenga W; Bleiker EM; Hahn DE; Van der Kolk LE; Sidharta GN; Aaronson NK
Fam Cancer; 2015 Dec; 14(4):629-36. PubMed ID: 25968807
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
Voorwinden JS; Jaspers JP
J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
[TBL] [Abstract][Full Text] [Related]
11. The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
Medendorp NM; van Maarschalkerweerd PEA; Murugesu L; Daams JG; Smets EMA; Hillen MA
Patient Educ Couns; 2020 Sep; 103(9):1692-1708. PubMed ID: 32278626
[TBL] [Abstract][Full Text] [Related]
12. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
[TBL] [Abstract][Full Text] [Related]
13. Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study.
Brédart A; Kop JL; Tüchler A; De Pauw A; Cano A; Dick J; Rhiem K; Devilee P; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S
Eur J Hum Genet; 2022 Sep; 30(9):1067-1075. PubMed ID: 35399119
[TBL] [Abstract][Full Text] [Related]
14. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
[TBL] [Abstract][Full Text] [Related]
15. "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
Gill G; Beard C; Storey K; Taylor S; Sexton A
Psychooncology; 2020 Aug; 29(8):1303-1311. PubMed ID: 32497346
[TBL] [Abstract][Full Text] [Related]
16. Patient-Centered Care in Breast Cancer Genetic Clinics.
Brédart A; Anota A; Dick J; Kuboth V; Lareyre O; De Pauw A; Cano A; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S; Kop JL
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29439543
[TBL] [Abstract][Full Text] [Related]
17. A descriptive study of BRCA1 testing and reactions to disclosure of test results.
Lynch HT; Lemon SJ; Durham C; Tinley ST; Connolly C; Lynch JF; Surdam J; Orinion E; Slominski-Caster S; Watson P; Lerman C; Tonin P; Lenoir G; Serova O; Narod S
Cancer; 1997 Jun; 79(11):2219-28. PubMed ID: 9179070
[TBL] [Abstract][Full Text] [Related]
18. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
19. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
Sheppard VB; Mays D; LaVeist T; Tercyak KP
J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
[TBL] [Abstract][Full Text] [Related]
20. Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.
Kwiatkowski F; Dessenne P; Laquet C; Petit MF; Bignon YJ
Eur J Hum Genet; 2012 Feb; 20(2):141-7. PubMed ID: 21934710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
